LMB In The News

Fabrice Gorrec, from the LMB’s crystallisation facility, is a finalist in the newly introduced Researcher of the Year category at the Cambridge Independent Science and Technology Awards 2018. The winners will be announced at a ceremony on 1st November. More…

Ribosome reader to Royal Society leader: a biologist’s road to the Nobel – Nature’s review of LMB group leader Venki Ramakrishnan’s account of his career. More…

In recent years, support has grown for the idea that the same aggregating protein can fold up into different toxic shapes, giving rise to distinct neurodegenerative diseases. Now, in the August 29 Nature, researchers led by Michel Goedert and Sjors Scheres at the MRC Laboratory of Molecular Biology in Cambridge, England, in collaboration with Bernardino […]

August 2018 marks the centenary of the birth of Frederick (Fred) Sanger (1918–2013), one of the most influential scientists of the 20th century. Few scientists transform a discipline in their lifetime. Fred Sanger did this, not once but twice. By devising methods for sequencing, he revolutionized our understanding of both proteins and nucleic acids gaining […]

A neuroscience milestone: a high-resolution digital snapshot of the adult fruit fly brain.  Researchers can now trace the path of any one neuron to any other neuron throughout the whole brain.  The research, lead by a team of scientists at the Howard Hughes Medical Institute’s Janelia Research Campus, required the collaboration of dozens of other […]

Electron cryo-microscopy is enabling drug designers to understand how protein targets in the body interact with potential therapeutics. Technology developed at LMB, such as sensitive detectors and analytical software, as well as collaborations between LMB scientists and industry is helping make this possible. More…